Antibiotic Resistance Market By Resistant Bacteria Type, Disease Indication, Drug Class, Route of Administration, Region| Absolute Markets Insights

[402] Antibiotic Resistance Market By Resistant Bacteria Type (Pseudomonas Aeruginosa, Clostridioides difficile (C. difficile), Carbapenem-resistant Enterobacteriaceae (CRE), Streptococcus pneumoniae (S. pneumoniae), Acinetobacter, Vancomycin-resistant Enterococci (VRE), Mycobacterium Tuberculosis (TB), Neisseria gonorrhoeae (N. gonorrhoeae), and Others); By Disease Indication (Complicated Urinary Tract Infections (cUTI), Complicated Intra-Abdominal Infections (cIAI), Community-Acquired Bacterial Pneumonia (CABP), Acute Skin and Skin Structure Infections (ABSSSI), Multidrug-Resistant (MDR) & Pulmonary Extensively Drug Resistant (XDR) Tuberculosis (TB) (MDR-TB & XDR-TB), Sepsis, Clostridium Difficile (C. difficile) Infections, and Others); By Drug Class (Antimycobacterials, Fluoroquinolones, Oxazolidinones, Tetracyclines, Penicillins, Antifolates, Combination Treatment, and Others); By Route of Administration (Oral, Topical, Intramuscular, and Intravenous (IV)); By End Use (Home Care, H
https://www.absolutemarketsinsights.com/reports/Antibiotic-Resistance-Market-2021---2029-876
Comments
Post a Comment